Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.
D000613:Aminobutyrates / Q000097:blood / Q000494:pharmacology / Q000652:urine; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D002228:Carbenicillin / Q000494:pharmacology; D004357:Drug Synergism; D004755:Enterobacteriaceae / Q000187:drug effects; D005839:Gentamicins / Q000097:blood / Q000494:pharmacology / Q000652:urine; D007273:Injections, Intramuscular; D007612:Kanamycin / Q000097:blood / Q000494:pharmacology* / Q000652:urine; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects
D000613:Aminobutyrates; D005839:Gentamicins; D007612:Kanamycin; D002228:Carbenicillin